ProductLife Group inaugurates new hub in Casablanca, placing Artificial Intelligence at the core of its Life Sciences strategy

ProductLife Group Webinar | 9 October 2025 - Online

Marketing Authorization Transfers (MATs) are increasingly common in today's biopharma industry, whether driven by product divestitures, outsourcing licensing, or strategic licensing deals. While often perceived as a regulatory formality, MATs actually generate a broad set of regulatory impacts and product development impacts that require careful planning and operational excellence.

Why this topic matters

• Product development impacts, including continuity of clinical and CMC data

• Regulatory impacts, with differing global and domestic frameworks to navigate

• Pharmacovigilance and quality system transitions

• Supply chain continuity to avoid product shortages

• Data compliance and IT system integrations

What you will gain from the webinar

This session - the first in a three-part series on Marketing Authorization Transfers - will equip participants with strategic and operational insights to handle both the regulatory and business dimensions of licensing transitions.

Learning objectives:

• Understand key regulatory impacts and operational considerations to accelerate licensing deals

• Explore strategies for outsourcing licensing effectively while maintaining compliance

• Identify risks, dependencies, and hidden complexities through robust due diligence

• Gain practical tips to ensure business continuity and product supply

• Review case examples of successful MATs and lessons learned

Meet the experts

• Philip Smith, Global Business Unit Head of Regulatory Affairs & Operations

• James Crook, Staff & Performance Director, Regulatory Affairs & Operations

• Nick Larsen, Data Migration Lead

• Chetan Javia (to be confirmed), Director, Sales Enablement & Operations

Event details

Register here